More importantly, the analysis of the cohort of TCGA showed that CTNNA2-MT patients had more tumor neoantigens than CTNNA2-WT patients (Mann-Whitney U test, p < 0.05 Figure 2A). This evidence concerns the gene CTNNA2 and neoplasm.